Elanco Animal Health reports strong Q3 results driven by innovative product sales growth
ELAN Elanco Animal Health Inc
$26.76 -0.30%
View chart & analysis → - 1Elanco Animal Health recorded an 11% reported revenue growth for Elanco in Q3.
- 2Innovative product sales increased by more than 40% year-over-year to reach $328 million.
- 3Elanco raised its annual innovative product sales target to $1.275 billion.
So what's the key point?
Elanco Animal Health reported strong results due to a significant increase in sales of its new products. The company raised its innovative product sales target to $1.275 billion.
Source The Motley Fool +1 · View original ↗
Today's 5 AI picks, all freeNothing hidden: past picks and how they did against the S&P 500.